Cargando…

Exploring the Role of Obesity in Dilated Cardiomyopathy Based on Bio-informatics Analysis

(1) Background: Obesity is a major risk factor for cardiovascular disease (CVD), contributing to increasing global disease burdens. Apart from heart failure, coronary artery disease, and arrhythmia, recent research has found that obesity also elevates the risk of dilated cardiomyopathy (DCM). The ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xuehua, Liu, Wei, Li, Huili, Ding, Jiaxing, Feng, Yu, Chen, Zhijian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783214/ https://www.ncbi.nlm.nih.gov/pubmed/36547458 http://dx.doi.org/10.3390/jcdd9120462

Ejemplares similares

Identification of Immune Markers in Dilated Cardiomyopathies with Heart Failure by Integrated Weighted Gene Coexpression Network Analysis
por: Wang, Xuehua, et al.
Publicado: (2022)

Quantum bio-informatics : from quantum information to bio-informatics
por: Accardi, Luigi, et al.
Publicado: (2011)

Human umbilical vein endothelial cells-derived exosomes enhance cardiac function after acute myocardial infarction by activating the PI3K/AKT signaling pathway
por: Liu, Wei, et al.
Publicado: (2022)

miR-186-5p Dysregulation in Serum Exosomes from Patients with AMI Aggravates Atherosclerosis via Targeting LOX-1
por: Ding, Jiaxing, et al.
Publicado: (2022)

MicroRNA-130a attenuates cardiac fibrosis after myocardial infarction through TGF-β/Smad signaling by directly targeting TGF-β receptor 1
por: Feng, Yu, et al.
Publicado: (2022)

Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy
por: Ding, Jiaxing, et al.
Publicado: (2021)

Obesity modifies the energetic phenotype of dilated cardiomyopathy
por: Rayner, Jennifer J, et al.
Publicado: (2021)

Arrhythmias in patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: Incidences and implications
por: Guan, Hongquan, et al.
Publicado: (2021)

The role of Asprosin in patients with dilated cardiomyopathy
por: Wen, Ming-Shien, et al.
Publicado: (2020)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Bio and health informatics meets cloud : BioVLab as an example
por: Chae, Heejoon, et al.
Publicado: (2013)

The Genetic Evaluation of Dilated Cardiomyopathy
por: Bui, Quan M., et al.
Publicado: (2023)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Role of Titin Missense Variants in Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2015)

The Role of Genetic Testing in the Evaluation of Dilated Cardiomyopathies
por: Agboola, Kolade M., et al.
Publicado: (2021)

The Molecular Role of Immune Cells in Dilated Cardiomyopathy
por: Wang, Enping, et al.
Publicado: (2023)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq
por: Fang, Chenggang, et al.
Publicado: (2022)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

A longitudinal study on BIO14.6 hamsters with dilated cardiomyopathy: micro-echocardiographic evaluation
por: Belfiore, Maria Paola, et al.
Publicado: (2011)

Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy
por: Zheng, Youyang, et al.
Publicado: (2022)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Analysis of the role of glucose metabolism-related genes in dilated cardiomyopathy based on bioinformatics
por: Chen, Keping, et al.
Publicado: (2023)

The Role of the Phylogenetic Diversity Measure, PD, in Bio-informatics: Getting the Definition Right
por: Faith, Daniel P.
Publicado: (2007)

Identification of Heparan Sulfate in Dilated Cardiomyopathy by Integrated Bioinformatics Analysis
por: Song, Wenyu, et al.
Publicado: (2022)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

BIPASS: BioInformatics Pipeline Alternative Splicing Services
por: Lacroix, Zoé, et al.
Publicado: (2007)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Metabolic manipulation in Dilated Cardiomyopathy: assessing the role of trimetazidine
por: Kapoor, Aditya, et al.
Publicado: (2015)

Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine
por: Jatain, Suman, et al.
Publicado: (2016)

Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy
por: Zhao, Lifang, et al.
Publicado: (2018)

Pathogenic Roles of Cardiac Fibroblasts in Pediatric Dilated Cardiomyopathy
por: Tsuru, Hirofumi, et al.
Publicado: (2023)

Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis
por: Gan, Ting, et al.
Publicado: (2023)

Evidence-Based Assessment of Genes in Dilated Cardiomyopathy
por: Jordan, Elizabeth, et al.
Publicado: (2021)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Exploring the Crosstalk Between LMNA and Splicing Machinery Gene Mutations in Dilated Cardiomyopathy
por: Zahr, Hind C., et al.
Publicado: (2018)

Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy
por: Li, Xuebiao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u5l0d50m18c1eel7hc2b5tlj9b